NYLXS - Free Software Events

Mon Nov 25 02:01:34 2024

EVENTS

FREE
SOFTWARE
INSTITUTE

POLITICS

JOBS

MEMBERS'
CORNER

MAILING
LIST

NYLXS Members have a lot to say and share but we don't keep many secrets. Join the Hangout Mailing List and say your peice.

DATE 2020-07-01

HANGOUT

2024-11-25 | 2024-10-25 | 2024-09-25 | 2024-08-25 | 2024-07-25 | 2024-06-25 | 2024-05-25 | 2024-04-25 | 2024-03-25 | 2024-02-25 | 2024-01-25 | 2023-12-25 | 2023-11-25 | 2023-10-25 | 2023-09-25 | 2023-08-25 | 2023-07-25 | 2023-06-25 | 2023-05-25 | 2023-04-25 | 2023-03-25 | 2023-02-25 | 2023-01-25 | 2022-12-25 | 2022-11-25 | 2022-10-25 | 2022-09-25 | 2022-08-25 | 2022-07-25 | 2022-06-25 | 2022-05-25 | 2022-04-25 | 2022-03-25 | 2022-02-25 | 2022-01-25 | 2021-12-25 | 2021-11-25 | 2021-10-25 | 2021-09-25 | 2021-08-25 | 2021-07-25 | 2021-06-25 | 2021-05-25 | 2021-04-25 | 2021-03-25 | 2021-02-25 | 2021-01-25 | 2020-12-25 | 2020-11-25 | 2020-10-25 | 2020-09-25 | 2020-08-25 | 2020-07-25 | 2020-06-25 | 2020-05-25 | 2020-04-25 | 2020-03-25 | 2020-02-25 | 2020-01-25 | 2019-12-25 | 2019-11-25 | 2019-10-25 | 2019-09-25 | 2019-08-25 | 2019-07-25 | 2019-06-25 | 2019-05-25 | 2019-04-25 | 2019-03-25 | 2019-02-25 | 2019-01-25 | 2018-12-25 | 2018-11-25 | 2018-10-25 | 2018-09-25 | 2018-08-25 | 2018-07-25 | 2018-06-25 | 2018-05-25 | 2018-04-25 | 2018-03-25 | 2018-02-25 | 2018-01-25 | 2017-12-25 | 2017-11-25 | 2017-10-25 | 2017-09-25 | 2017-08-25 | 2017-07-25 | 2017-06-25 | 2017-05-25 | 2017-04-25 | 2017-03-25 | 2017-02-25 | 2017-01-25 | 2016-12-25 | 2016-11-25 | 2016-10-25 | 2016-09-25 | 2016-08-25 | 2016-07-25 | 2016-06-25 | 2016-05-25 | 2016-04-25 | 2016-03-25 | 2016-02-25 | 2016-01-25 | 2015-12-25 | 2015-11-25 | 2015-10-25 | 2015-09-25 | 2015-08-25 | 2015-07-25 | 2015-06-25 | 2015-05-25 | 2015-04-25 | 2015-03-25 | 2015-02-25 | 2015-01-25 | 2014-12-25 | 2014-11-25 | 2014-10-25 | 2014-09-25 | 2014-08-25 | 2014-07-25 | 2014-06-25 | 2014-05-25 | 2014-04-25 | 2014-03-25 | 2014-02-25 | 2014-01-25 | 2013-12-25 | 2013-11-25 | 2013-10-25 | 2013-09-25 | 2013-08-25 | 2013-07-25 | 2013-06-25 | 2013-05-25 | 2013-04-25 | 2013-03-25 | 2013-02-25 | 2013-01-25 | 2012-12-25 | 2012-11-25 | 2012-10-25 | 2012-09-25 | 2012-08-25 | 2012-07-25 | 2012-06-25 | 2012-05-25 | 2012-04-25 | 2012-03-25 | 2012-02-25 | 2012-01-25 | 2011-12-25 | 2011-11-25 | 2011-10-25 | 2011-09-25 | 2011-08-25 | 2011-07-25 | 2011-06-25 | 2011-05-25 | 2011-04-25 | 2011-03-25 | 2011-02-25 | 2011-01-25 | 2010-12-25 | 2010-11-25 | 2010-10-25 | 2010-09-25 | 2010-08-25 | 2010-07-25 | 2010-06-25 | 2010-05-25 | 2010-04-25 | 2010-03-25 | 2010-02-25 | 2010-01-25 | 2009-12-25 | 2009-11-25 | 2009-10-25 | 2009-09-25 | 2009-08-25 | 2009-07-25 | 2009-06-25 | 2009-05-25 | 2009-04-25 | 2009-03-25 | 2009-02-25 | 2009-01-25 | 2008-12-25 | 2008-11-25 | 2008-10-25 | 2008-09-25 | 2008-08-25 | 2008-07-25 | 2008-06-25 | 2008-05-25 | 2008-04-25 | 2008-03-25 | 2008-02-25 | 2008-01-25 | 2007-12-25 | 2007-11-25 | 2007-10-25 | 2007-09-25 | 2007-08-25 | 2007-07-25 | 2007-06-25 | 2007-05-25 | 2007-04-25 | 2007-03-25 | 2007-02-25 | 2007-01-25 | 2006-12-25 | 2006-11-25 | 2006-10-25 | 2006-09-25 | 2006-08-25 | 2006-07-25 | 2006-06-25 | 2006-05-25 | 2006-04-25 | 2006-03-25 | 2006-02-25 | 2006-01-25 | 2005-12-25 | 2005-11-25 | 2005-10-25 | 2005-09-25 | 2005-08-25 | 2005-07-25 | 2005-06-25 | 2005-05-25 | 2005-04-25 | 2005-03-25 | 2005-02-25 | 2005-01-25 | 2004-12-25 | 2004-11-25 | 2004-10-25 | 2004-09-25 | 2004-08-25 | 2004-07-25 | 2004-06-25 | 2004-05-25 | 2004-04-25 | 2004-03-25 | 2004-02-25 | 2004-01-25 | 2003-12-25 | 2003-11-25 | 2003-10-25 | 2003-09-25 | 2003-08-25 | 2003-07-25 | 2003-06-25 | 2003-05-25 | 2003-04-25 | 2003-03-25 | 2003-02-25 | 2003-01-25 | 2002-12-25 | 2002-11-25 | 2002-10-25 | 2002-09-25 | 2002-08-25 | 2002-07-25 | 2002-06-25 | 2002-05-25 | 2002-04-25 | 2002-03-25 | 2002-02-25 | 2002-01-25 | 2001-12-25 | 2001-11-25 | 2001-10-25 | 2001-09-25 | 2001-08-25 | 2001-07-25 | 2001-06-25 | 2001-05-25 | 2001-04-25 | 2001-03-25 | 2001-02-25 | 2001-01-25 | 2000-12-25 | 2000-11-25 | 2000-10-25 | 2000-09-25 | 2000-08-25 | 2000-07-25 | 2000-06-25 | 2000-05-25 | 2000-04-25 | 2000-03-25 | 2000-02-25 | 2000-01-25 | 1999-12-25

Key: Value:

MESSAGE

DATE

2020-07-11

FROM

From: "Pharmacy Times Continuing Education - PTCE"

SUBJECT

Subject: [Hangout - NYLXS] COVID-19 Live Free CE Webinar!

From hangout-bounces-at-nylxs.com Sun Jul 12 17:15:06 2020
Return-Path:
X-Original-To: archive-at-mrbrklyn.com
Delivered-To: archive-at-mrbrklyn.com
Received: from www2.mrbrklyn.com (www2.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id 0009E163F7F;
Sun, 12 Jul 2020 17:15:05 -0400 (EDT)
X-Original-To: hangout-at-www2.mrbrklyn.com
Delivered-To: hangout-at-www2.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id 9ADD9163F7A; Sun, 12 Jul 2020 17:15:02 -0400 (EDT)
Resent-From: Ruben Safir
Resent-Date: Sun, 12 Jul 2020 17:15:02 -0400
Resent-Message-ID: <20200712211502.GB32530-at-www2.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from mx42.a.outbound.createsend.com (mx42.a.outbound.createsend.com
[203.55.21.42]) by mrbrklyn.com (Postfix) with ESMTP id E6AC8163F9E
for ; Sat, 11 Jul 2020 17:02:23 -0400 (EDT)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cm; d=pharmacytimes.org;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
i=ptce-at-pharmacytimes.org; bh=g9+APuFbj/a5wh46H9JmGmB3fCg=;
b=DS7hedhPVC92SamDJWcU19WZuymAqdh9BH5Od/4vBPYKnPajO8jHjkWyZeKejHEfhZ46K6CIWpmO
zyzU7Cw+j2DuqCYlcF16QyVSqoTUXKafrgKyVJQaSUDAKjvJW9K1i2eg1vBji2AxGMOeHedvcer3
coDA/udUncE/tH4CUQg=
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cs2013; d=cmail2.com;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
bh=g9+APuFbj/a5wh46H9JmGmB3fCg=;
b=Olv7n0ibYeFBjQOX48U0wm25HfjIPhkBHlJJBBvy3HD0eV4MnWx0TbEJqrOTBuUaZxQU17l65mB/
VnUfFsUg5vFfhNccB2EWUivJIGhq8qJ1WNOyg8CHFrHSvVo1G2zyyzkXeJOinwQWLvkoyTpm43Ik
BmgRJJu9kcTm+MTINOo=
From: "Pharmacy Times Continuing Education - PTCE"
To: "Ruben Safir"
Date: Sun, 12 Jul 2020 07:02:12 +1000
MIME-Version: 1.0
X-Mailer: Create Send
X-Complaints-To: abuse-at-cmail20.com
X-Feedback-ID: CA1-j-qhjhudt:LI1-j-ekrikh:CL1-j-jruiiu:createSEND
Message-ID:
Subject: [Hangout - NYLXS] COVID-19 Live Free CE Webinar!
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.30rc1
Precedence: list
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,

List-Archive:
List-Post:
List-Help:
List-Subscribe: ,

Reply-To: ptce-at-pharmacytimes.org
Content-Type: multipart/mixed; boundary="===============1486874644=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"

--===============1486874644==
Content-Type: multipart/alternative;
boundary="_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_"; charset=utf-8

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qhjhudt-ttqvtdkr-p/

Live Webinar!

Overview of COVID-19: Evolving Investigational Treatment Landscape and Em=
erging Data

Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Examine the burden of the COVID-19 pandemic and potential therapies under=
accelerated development including antivirals and immunomodulatorsExplore=
emerging efficacy and safety data on therapies under investigation for C=
OVID-19, as well as ongoing research in vaccine development

Can't join us for this webinar?

Check out these other live programs!

Managing Therapy

in Heart Failure:

Updates for

Pharmacists

July 14, 2020

A Pharmacist=E2=80=99s Perspective in Hyperkalemia: Improving Clinical Ou=
tcomes With Safe and Effective Treatment Options

July 16, 2020

Click the icon to the left to add this

Live CE Webinar to your calendar!

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qhjhudt-l-x Preferences https:=
//pharmacytimescontinuingeducation.updatemyprofile.com/j-qhjhudt-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimesco=
ntinuingeducation.cmail20.com/t/j-u-qhjhudt-ttqvtdkr-c/

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">

=20
t:400,700,400italic|Roboto:400,700,400italic,700italic" rel=3D"stylesheet=
" type=3D"text/css">

ize-adjust: 100%;">

eight:0;overflow:hidden;font-size:0;">Overview of COVID-19: Evolving Inve=
stigational Treatment Landscape and Emerging Data‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">

;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">

00%;">

ft;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 140px; w=
idth: 140px;width: calc(14000% - 78120px);padding: 10px 0 5px 0;color: #0=
00;font-family: Montserrat,DejaVu Sans,Verdana,sans-serif;">
=20

left;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 139px=
; width: 139px;width: calc(14100% - 78680px);padding: 10px 0 5px 0;text-a=
lign: right;color: #000;font-family: Montserrat,DejaVu Sans,Verdana,sans-=
serif;">

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/=
j-e-qhjhudt-ttqvtdkr-h/">Click here

n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">

x;line-height: 32px;Margin-top: 6px;Margin-bottom: 14px;color: #2f353e;fo=
nt-family: PT Sans,Trebuchet MS,sans-serif;" align=3D"center">

eader">;color: #2f353e;" href=3D"https://pharmacytimescontinuingeducation.cmail2=
0.com/t/j-l-qhjhudt-ttqvtdkr-r/">eight: auto;width: 100%;border: 0;max-width: 205px;" src=3D"http://i1.cma=
il20.com/ei/j/88/91D/0BF/041230/csfinal/AllPTCElogo.png" alt=3D"" width=3D=
"205">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

o-repeat url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_CO=
VID_Email_071020v1.png) #ffffff;background-position: 19% 10%;background-i=
mage: url(http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_COVID=
_Email_071020v1.png);background-repeat: no-repeat;background-size: cover;=
">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

ize: 1px;">

=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 16px;lin=
e-height: 24px;text-align: center;" lang=3D"x-size-16">t-montserrat">Live Webinar!>

=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 17px;lin=
e-height: 26px;text-align: center;" lang=3D"x-size-20">t-montserrat">Overview of COVID-19:=
Evolving Investigational Treatment Landscape and Emerging Data<=
/span>

=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qhjhudt-ttqvtdkr-y/">isplay: block;height: auto;width: 100%;max-width: 227px;" alt=3D"" width=3D=
"227" src=3D"http://i1.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_He=
patocellularCarcinoma_Button_070919v1-c279575da84192f.png">

=20

op: 20px;">

ize: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

mal;line-height: 19px;" align=3D"center">
;max-width: 209px;" alt=3D"" width=3D"209" src=3D"http://i2.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/DTlogo-990b6d0000028a3c.png">

=20

op: 20px;">

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Educational Objective=
s

Upon completion of this educational activity, participants will be ab=
le to:

=20

rtical-align: middle;">

padding: 0;list-style-type: disc;">
top: 0;Margin-bottom: 0;Margin-left: 0;font-family: montserrat,dejavu san=
s,verdana,sans-serif;font-size: 15px;line-height: 23px;" lang=3D"x-size-1=
5">Examine =
the burden of the COVID-19 pandemic and potential therapies under acceler=
ated development including antivirals and immunomodulators<=
/li>
left: 0;font-family: montserrat,dejavu sans,verdana,sans-serif;font-size:=
15px;line-height: 23px;" lang=3D"x-size-15">at">Explore emerging efficacy and safety da=
ta on therapies under investigation for COVID-19, as well as ongoing rese=
arch in vaccine=20
development

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qhjhudt-ttqvtdkr-j/">isplay: block;height: auto;width: 100%;max-width: 226px;" alt=3D"" width=3D=
"226" src=3D"http://i3.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_Bl=
ue_LearnMore_071619v1-99079e028a028a3c.png">

=20

op: 20px;">

ize: 1px;">

=20

=20

ize: 8px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Can't join us for this webi=
nar?

Check out these other live programs!

=20

ize: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">Managing Therapy

in Heart Failure:

Updates for

Pharmacists

July 14, 2020

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qhjhudt-ttqvtdkr-t/">isplay: block;height: auto;width: 100%;max-width: 208px;" alt=3D"" width=3D=
"208" src=3D"http://i4.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_Bu=
ttons_LearnMore_White1-b25cdb164131fbe0.png">

=20

op: 20px;">

ize: 1px;">

=20

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;ma=
x-width: 320px;min-width: 300px; width: 320px;width: calc(12300px - 2000%=
);Float: left;">
=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 15px;lin=
e-height: 23px;text-align: center;" lang=3D"x-size-15">t-montserrat">A Pharmacist’s =
Perspective in Hyperkalemia: Improving Clinical Outcomes With Safe and Ef=
fective Treatment Options

July 16, 2020

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qhjhudt-ttqvtdkr-i/">isplay: block;height: auto;width: 100%;max-width: 208px;" alt=3D"" width=3D=
"208" src=3D"http://i5.cmail20.com/ei/j/88/91D/0BF/041230/csfinal/PTCE_Bu=
ttons_LearnMore_White2-b2515b18f1c02090.png">

=20

op: 20px;">

ize: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

=20

0px;min-width: 320px; width: 320px;width: calc(28000% - 167400px);overflo=
w-wrap: break-word;word-wrap: break-word;word-break: break-word;">

;display: table;width: 100%;">

#000;font-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-s=
erif;Float: left;max-width: 320px;min-width: 200px; width: 320px;width: c=
alc(72200px - 12000%);">
=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qhjhudt-ttqvtdkr-d/">image gnd-corner-image-center gnd-corner-image-top gnd-corner-image-botto=
m" style=3D"border: 0;display: block;height: auto;width: 100%;max-width: =
102px;" alt=3D"" width=3D"102" src=3D"http://i6.cmail20.com/ei/j/88/91D/0=
BF/041230/csfinal/whitecalendaricon-20ea4978c823df6f.png">

=20

000;font-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-ser=
if;Float: left;max-width: 400px;min-width: 320px; width: 320px;width: cal=
c(8000% - 47600px);">
=20

size: 1px;">

=20

rtical-align: middle;">

t,dejavu sans,verdana,sans-serif;text-align: center;">-montserrat">Click the icon to the left to =
add this

Live CE Webinar to your calendar!

=20

=20

size: 20px;">

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

mal;line-height: 19px;" align=3D"center">
;max-width: 600px;" alt=3D"" width=3D"600" src=3D"http://i7.cmail20.com/e=
i/j/88/91D/0BF/041230/csfinal/UpdatedPTCE_Rebrand_EmailBanner_042420v2-99=
00000000079e3c.jpg">

=20

=20

size: 20px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;">

=20

=20

size: 20px;">

=20
=20

max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 1674=
00px);overflow-wrap: break-word;word-wrap: break-word;word-break: break-w=
ord;">

;display: table;width: 100%;">

e: 12px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans=
,Verdana,sans-serif;Float: left;max-width: 400px;min-width: 320px; width:=
320px;width: calc(8000% - 47600px);">

op: 10px;Margin-bottom: 10px;">
=20

Pharmacy Times Continuing Education™ –=
an MJH Life Sciences brand

Copyright 2020 © Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512

p: 18px;">
=20

ize: 12px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sa=
ns,Verdana,sans-serif;Float: left;max-width: 320px;min-width: 200px; widt=
h: 320px;width: calc(72200px - 12000%);">

op: 10px;Margin-bottom: 10px;">

=20
=20
=20

exactly;">
0.1s ease-in;color: #ffffff;border-radius: 2px;display: inline-block;fon=
t-size: 11px;font-weight: bold;line-height: 19px;text-align: left;border-=
style: solid;border-width: 4px 7px 3px 4px;mso-border-width-alt: 4px 8px =
8px 8px;background-color: gray;border-color: gray;mso-border-color-alt: g=
ray;" href=3D"https://pharmacytimescontinuingeducation.forwardtomyfriend.=
com/j-ttqvtdkr-EE17CB78-qhjhudt-l-k" lang=3D"en">
;margin-right: 2px;vertical-align: -3px;" src=3D"http://i2.cmail20.com/st=
atic/eb/master/13-the-blueprint-3/images/forward-icon-at-2x.png" width=3D"16=
" height=3D"16" border=3D"0" alt=3D"">
">Forward

o;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 16=
7400px);overflow-wrap: break-word;word-wrap: break-word;word-break: break=
-word;">

;display: table;width: 100%;">

px;line-height: 19px;color: #000;font-family: Montserrat,DejaVu Sans,Verd=
ana,sans-serif;">

op: 10px;Margin-bottom: 10px;">

: opacity 0.1s ease-in;color: #000;" href=3D"https://pharmacytimescontinu=
ingeducation.updatemyprofile.com/j-qhjhudt-EE17CB78-=
ttqvtdkr-u" lang=3D"en">Preferences | style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;col=
or: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t=
/j-u-qhjhudt-ttqvtdkr-o/">Unsubscribe

rtant;display: block !important;height: 1px !important;width: 1px !import=
ant;border: 0 !important;margin: 0 !important;padding: 0 !important;" src=
=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/j-o-qhjhudt-=
ttqvtdkr/o.gif" width=3D"1" height=3D"1" border=3D"0" alt=3D"">
=

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_--

--===============1486874644==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1486874644==--

--===============1486874644==
Content-Type: multipart/alternative;
boundary="_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_"; charset=utf-8

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qhjhudt-ttqvtdkr-p/

Live Webinar!

Overview of COVID-19: Evolving Investigational Treatment Landscape and Em=
erging Data

Monday, July 20, 2020

7 PM - 8 PM ET

1.0 Live CE Credit

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Examine the burden of the COVID-19 pandemic and potential therapies under=
accelerated development including antivirals and immunomodulatorsExplore=
emerging efficacy and safety data on therapies under investigation for C=
OVID-19, as well as ongoing research in vaccine development

Can't join us for this webinar?

Check out these other live programs!

Managing Therapy

in Heart Failure:

Updates for

Pharmacists

July 14, 2020

A Pharmacist=E2=80=99s Perspective in Hyperkalemia: Improving Clinical Ou=
tcomes With Safe and Effective Treatment Options

July 16, 2020

Click the icon to the left to add this

Live CE Webinar to your calendar!

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qhjhudt-l-x Preferences https:=
//pharmacytimescontinuingeducation.updatemyprofile.com/j-qhjhudt-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimesco=
ntinuingeducation.cmail20.com/t/j-u-qhjhudt-ttqvtdkr-c/

--_ebae2282-d0f6-4caa-acaa-c25a1a1bde10_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">

=20
t:400,700,400italic|Roboto:400,700,400italic,700italic" rel=3D"stylesheet=
" type=3D"text/css">

ize-adjust: 100%;">

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">

;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">

00%;">

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #000;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/=
j-e-qhjhudt-ttqvtdkr-h/">Click here

n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">

x;line-height: 32px;Margin-top: 6px;Margin-bottom: 14px;color: #2f353e;fo=
nt-family: PT Sans,Trebuchet MS,sans-serif;" align=3D"center">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

ize: 1px;">

=20

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 16px;lin=
e-height: 24px;text-align: center;" lang=3D"x-size-16">t-montserrat">Live Webinar!>